Testing steroid eye drops for bacterial corneal ulcers
Part of Eyes & vision, Infections clinical trials.
This study tests whether an anti-swelling eye drop (fluorometholone) helps people with bacterial eye ulcers heal faster when added to standard antibiotics. It may be an option if you have a bacterial ulcer and have already started antibiotic drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a bacterial infection that caused an ulcer (sore) on the front of your eye.
- The ulcer is classed as mild, moderate, or severe based on size and depth.
- You have already taken antibiotic eye drops for at least 2–4 days.
- You do not have a fungal, herpes, or amoeba infection, and you are not currently using steroid eye drops or pills for this episode.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial tests if an antibiotic injection directly into the cornea can help when standard eye drops are not working for a stubborn bacterial eye infection.
This Phase 2 trial tests BRM424 eye drops in adults with neurotrophic keratitis (a weakened, slow-healing cornea) to see if they help and are safe over 28 days. You may be able to join if your condition matches Stage 2 or Stage 3 and you meet the safety rules.
This trial tests a new type of antibiotic eye drop for people with serious eye infections that don't respond to standard antibiotics. It aims to see if these drops can safely treat the infection and help improve vision.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
Hear when a new Keratitis Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.